Analysis and Commentary STEVEN GROSSMAN 3/27/20 Analysis and Commentary STEVEN GROSSMAN 3/27/20 Coronavirus, Pandemic Preparedness, and Beyond Read More STEVEN GROSSMAN 7/24/18 STEVEN GROSSMAN 7/24/18 “First, do no harm” Read More Analysis and Commentary STEVEN GROSSMAN 11/10/17 Analysis and Commentary STEVEN GROSSMAN 11/10/17 Whatever Makes FDA Stronger (in Resources) ... Read More Analysis and Commentary STEVEN GROSSMAN 10/27/17 Analysis and Commentary STEVEN GROSSMAN 10/27/17 Building a Truely 21st Century Regulatory Agency Read More Analysis and Commentary STEVEN GROSSMAN 10/13/17 Analysis and Commentary STEVEN GROSSMAN 10/13/17 The FDA Deserves Special Consideration at Budget-Time Read More Analysis and Commentary STEVEN GROSSMAN 4/28/17 Analysis and Commentary STEVEN GROSSMAN 4/28/17 Success ... But More Work Will Be Needed! Read More Analysis and Commentary STEVEN GROSSMAN 2/3/17 Analysis and Commentary STEVEN GROSSMAN 2/3/17 One Size Still Does Not Fit All Read More Analysis and Commentary STEVEN GROSSMAN 8/20/16 Analysis and Commentary STEVEN GROSSMAN 8/20/16 Exceptionalism in Predictably Challenging Times Read More Analysis and Commentary STEVEN GROSSMAN 7/29/16 Analysis and Commentary STEVEN GROSSMAN 7/29/16 FDA Must Do More ... But How Much More for Less? Read More Analysis and Commentary STEVEN GROSSMAN 7/22/16 Analysis and Commentary STEVEN GROSSMAN 7/22/16 No Taking Sides Here at the Alliance! Read More Analysis and Commentary STEVEN GROSSMAN 6/17/16 Analysis and Commentary STEVEN GROSSMAN 6/17/16 Let's Praise FDA for What is Going Well! Read More Advocacy at a Glance STEVEN GROSSMAN 6/17/16 Advocacy at a Glance STEVEN GROSSMAN 6/17/16 Senate Considers CJS Appropriations Without Ag/FDA Read More Analysis and Commentary STEVEN GROSSMAN 10/16/15 Analysis and Commentary STEVEN GROSSMAN 10/16/15 FDA Mission Still "at Risk" Says Science Board Read More Analysis and Commentary STEVEN GROSSMAN 12/5/14 Analysis and Commentary STEVEN GROSSMAN 12/5/14 Why Unfunded Mandates Can Be a Real Problem for FDA Read More
Analysis and Commentary STEVEN GROSSMAN 3/27/20 Analysis and Commentary STEVEN GROSSMAN 3/27/20 Coronavirus, Pandemic Preparedness, and Beyond Read More
Analysis and Commentary STEVEN GROSSMAN 11/10/17 Analysis and Commentary STEVEN GROSSMAN 11/10/17 Whatever Makes FDA Stronger (in Resources) ... Read More
Analysis and Commentary STEVEN GROSSMAN 10/27/17 Analysis and Commentary STEVEN GROSSMAN 10/27/17 Building a Truely 21st Century Regulatory Agency Read More
Analysis and Commentary STEVEN GROSSMAN 10/13/17 Analysis and Commentary STEVEN GROSSMAN 10/13/17 The FDA Deserves Special Consideration at Budget-Time Read More
Analysis and Commentary STEVEN GROSSMAN 4/28/17 Analysis and Commentary STEVEN GROSSMAN 4/28/17 Success ... But More Work Will Be Needed! Read More
Analysis and Commentary STEVEN GROSSMAN 2/3/17 Analysis and Commentary STEVEN GROSSMAN 2/3/17 One Size Still Does Not Fit All Read More
Analysis and Commentary STEVEN GROSSMAN 8/20/16 Analysis and Commentary STEVEN GROSSMAN 8/20/16 Exceptionalism in Predictably Challenging Times Read More
Analysis and Commentary STEVEN GROSSMAN 7/29/16 Analysis and Commentary STEVEN GROSSMAN 7/29/16 FDA Must Do More ... But How Much More for Less? Read More
Analysis and Commentary STEVEN GROSSMAN 7/22/16 Analysis and Commentary STEVEN GROSSMAN 7/22/16 No Taking Sides Here at the Alliance! Read More
Analysis and Commentary STEVEN GROSSMAN 6/17/16 Analysis and Commentary STEVEN GROSSMAN 6/17/16 Let's Praise FDA for What is Going Well! Read More
Advocacy at a Glance STEVEN GROSSMAN 6/17/16 Advocacy at a Glance STEVEN GROSSMAN 6/17/16 Senate Considers CJS Appropriations Without Ag/FDA Read More
Analysis and Commentary STEVEN GROSSMAN 10/16/15 Analysis and Commentary STEVEN GROSSMAN 10/16/15 FDA Mission Still "at Risk" Says Science Board Read More
Analysis and Commentary STEVEN GROSSMAN 12/5/14 Analysis and Commentary STEVEN GROSSMAN 12/5/14 Why Unfunded Mandates Can Be a Real Problem for FDA Read More
